Used in pharmaceutical research as a protease inhibitor, particularly in the development of antiviral agents. Shows activity against viral enzymes such as those in hepatitis C and other RNA viruses by blocking key catalytic sites. Its structure allows high selectivity and binding affinity, making it a candidate for optimizing drug potency and metabolic stability. Also explored in peptide-based therapeutics for improved bioavailability and resistance profiles.